Cantini, L.; Bastianelli, L.; Lupi, A.; Pinterpe, G.; Pecci, F.; Belletti, G.; Stoico, R.; Vitarelli, F.; Moretti, M.; Onori, N.;
et al. Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J. Clin. Med. 2021, 10, 1503.
https://doi.org/10.3390/jcm10071503
AMA Style
Cantini L, Bastianelli L, Lupi A, Pinterpe G, Pecci F, Belletti G, Stoico R, Vitarelli F, Moretti M, Onori N,
et al. Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. Journal of Clinical Medicine. 2021; 10(7):1503.
https://doi.org/10.3390/jcm10071503
Chicago/Turabian Style
Cantini, Luca, Lucia Bastianelli, Alessio Lupi, Giada Pinterpe, Federica Pecci, Giovanni Belletti, Rosa Stoico, Francesca Vitarelli, Marco Moretti, Nicoletta Onori,
and et al. 2021. "Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy" Journal of Clinical Medicine 10, no. 7: 1503.
https://doi.org/10.3390/jcm10071503
APA Style
Cantini, L., Bastianelli, L., Lupi, A., Pinterpe, G., Pecci, F., Belletti, G., Stoico, R., Vitarelli, F., Moretti, M., Onori, N., Giampieri, R., Rocchi, M. B. L., & Berardi, R.
(2021). Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. Journal of Clinical Medicine, 10(7), 1503.
https://doi.org/10.3390/jcm10071503